Decheng Capital Global Life Sciences Fund IV, L.P. 13D and 13G filings for CG Oncology, Inc. Common stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:40 pm Purchase | 2024-12-31 | 13G | CG Oncology, Inc. Common stock CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | 6,371,669 8.400% | 912,859 (+16.72%) | Filing |
| 2024-04-09 7:12 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | 5,458,810 8.200% | 400,000 (+7.91%) | Filing |
| 2024-02-08 5:17 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | 5,058,810 7.600% | 5,058,810 (New Position) | Filing |